Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Resource Centers
    • mTBI Resource Center
  • Career
    • Practice Management
      • Benchmarking
      • Reimbursement & Coding
      • Care Team
      • Legal
      • Operations
      • Quality & Safety
    • Awards
    • Certification
    • Compensation
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • Brief19
    • By the Numbers
    • Coding Wizard
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Images in EM
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • ACEP.org
    • ACEP Knowledge Quiz
    • Issue Archives
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Studies Test Common Cardiac-Arrest Advanced Life Support Practices

By Ryan Patrick Radecki, MD, MS | on October 16, 2018 | 2 Comments
Pearls From the Medical Literature
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version
SHUTTERSTOCK.com

Again, as expected with cardiac arrest not seen on television, overall outcomes were dismal. Survival in the first 72 hours was 13.1 percent in the ETI cohort and 13.6 percent with SGA, and a good outcome was observed in 6.8 percent and 6.4 percent, respectively. Unlike the epinephrine trial, however, outcomes remained essentially parallel at all time points in the study.

You Might Also Like
  • Amiodarone, Lidocaine, Placebo Treatments Compared for Patients with Out-of-Hospital Cardiac Arrest
  • Survival After Cardiac Arrest May Depend on Which EMS Agency Shows Up
  • Pediatric In-Hospital Cardiac Arrest: Lower Survival During Nights, Weekends
Explore This Issue
ACEP Now: Vol 37 – No 10 – October 2018

This study featured several interesting quirks. Patients treated by paramedics randomized to the ETI cohort were far less likely to have any advanced airway attempted, with almost 25 percent of those in the ETI cohort simply receiving no airway attempt compared with 14 percent of those in the SGA group. These patients were managed with bag-valve-mask ventilation as indicated, and the overall rate of good outcome in these patients measured approximately 17 percent. Only 2.3 percent of those in whom an ETI was attempted had a good outcome compared with only 3.2 percent of those in whom SGA was attempted.

Caution: Beware imagining a causal relationship between attempting an advanced airway and poorer outcomes. It is far more likely individual patient factors associated with a better prognosis led to the difference in management strategies, but these data cannot definitively answer questions regarding the necessity of an advanced airway.

The PART study, conducted in the United States and enrolling 3,004 patients, was similar, although with minor differences in design. Rather than randomizing at the individual paramedic level, randomization occurred at the EMS agency level and included crossover periods for each. Additionally, the SGA device used was a laryngeal tube, the most commonly used SGA in the United States.

These authors observed outcomes similar to AIRWAYS-2, with a 72-hour survival of 15.4 percent in the ETI cohort compared to 18.3 percent with SGA. Neurological survival also favored SGA, with good outcomes occurring in only 5 percent of those randomized to ETI compared with 7.1 percent for SGA.

This study is also full of quirks relating to the individual agencies and the devices used. A handful of agencies were made up of EMS providers with only basic life support training. Patients randomized to ETI enrolled by these cohorts received noninvasive ventilation while awaiting the arrival of an advanced life support provider. Additionally, the overall rate of initial airway success was only 51.6 percent with ETI compared to 90.3 percent with SGA. Only one attempt was mandated, but any potential delay or interruption of resuscitative efforts may be interpreted to have deleterious effects on outcomes for the ETI cohort.

Pages: 1 2 3 | Single Page

Topics: AirwayAirway ManagementEndotracheal IntubationEpinephrineIntubationSupraglottic Airway

Related

  • Why the Nonrebreather Should be Abandoned

    December 3, 2025 - 0 Comment
  • Non-Invasive Positive Pressure Ventilation in the Emergency Department

    October 1, 2025 - 0 Comment
  • What’s in The Drug Pipeline These Days?

    August 4, 2025 - 0 Comment

Current Issue

ACEP Now: November 2025

Download PDF

Read More

About the Author

Ryan Patrick Radecki, MD, MS

Ryan Patrick Radecki, MD, MS, is an emergency physician and informatician with Christchurch Hospital in Christchurch, New Zealand. He is the Annals of Emergency Medicine podcast co-host and Journal Club editor and can be found on Twitter @emlitofnote.

View this author's posts »

2 Responses to “Studies Test Common Cardiac-Arrest Advanced Life Support Practices”

  1. October 28, 2018

    William Reed Reply

    Regarding the PARAMEDIC2 trial reviewed by Dr. Radecki.

    First, love the Princess Bride reference.

    Second, I would respectively offer another interpretation of the study.

    The study shows that epinephrine in OHCA will likely not improve “neuro-intact” survival if:

    1. Your EMS agency does not give the drug earlier than a median of 14.8 minutes after arrival.

    And,

    2. Your EMS agency has a very low overall survival rate for OHCA (1/5th that of the great state of Oregon’s – 2017 CARES data).

    Close, but no cigar.

    Repeating this study in the US with EMS agencies with a CPR fraction greater than 90% and who give Epi early (less than 10 minutes after EMS arrival) would help better define the utility of this drug in OHCA.

    Respectfully submitted “as you wish.”

    WJR

    • November 1, 2018

      Ryan Radecki Reply

      Thanks for the comment, William.

      I agree with all your points.

      Generalizability of a study is always of concern – if a study’s population and practices do not reflect your own, it limits the applicability to your setting. It blurs the line between practice-defining and hypothesis-generating, as you note, where either a subgroup analysis may be more informative, or another type of trial altogether.

      Cheers,
      Ryan

Leave a Reply Cancel Reply

Your email address will not be published. Required fields are marked *


*
*


Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603